FT825
FT825-101
Phase 1 small_molecule active
Quick answer
FT825 for Advanced Solid Tumor is a Phase 1 program (small_molecule) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active